Get started

Healthcare

$AXGN can fall in the next daysContextual immersion trading strategy idea. AxoGen provides surgical solutions for physical damage or transection to peripheral nerves. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price in the next days. So I opened a short position from $7,22; stop-loss — $7,84. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:AXGNShort
by KozakHlib
$CODX can rise in the next daysContextual immersion trading strategy idea. Co-Diagnostics is a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests. Due to the spread of COVID-19, the demand for the company`s services rose. The demand for shares of the company looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position from $13,31; stop-loss — $12,62. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:CODXLong
by KozakHlib
2
$CDTX can rise in the next daysContextual immersion trading strategy idea. Cidara Therapeutics is a biotechnology company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases The demand for shares of the company looks higher than the supply. Due to the spread of COVID-19, the demand for the company`s services rose. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $2,82; stop-loss — $2,59. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:CDTXLong
by KozakHlib
$ELMD can rise in the next daysContextual immersion trading strategy idea. The demand for shares of Electromed looks higher than the supply. The company develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation therapy in pulmonary care. Due to the spread of COVID-19, the demand for the company`s products rose. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $12,10; st0p-loss — $11,50. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
AMEX:ELMDLong
by KozakHlib
$IMMU can rise in the next daysContextual immersion trading strategy idea. The demand for shares of Immunomedics looks higher than the supply. It is a clinical-stage biopharmaceutical company, which develops monoclonal antibody-based products for the targeted treatment of cancer. On 06APR the company announced that its Phase 3 confirmatory ASCENT study will be halted due to compelling evidence of efficacy. This drug has the potential to be the first FDA-approved conjugate for the treatment of metastatic triple-negative breast cancer — finance.yahoo.com This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $19,37; stop-loss — $18,60. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
ILong
by KozakHlib
$CBPO can fall in the next daysContextual immersion trading strategy idea. The demand for shares of China Biologic Products Holdings looks lower than the supply. This and other conditions can cause a fall in the share price in the next days. So I opened a short position from $99,86; stop-loss — $102,65. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
CShort
by KozakHlib
$MNOV can rise in the next daysContextual immersion trading strategy idea. The demand for shares of MediciNova looks higher than the supply. The company focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs. Due to the spread of COVID-19, the demand for the company`s services rose. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $4,41; stop-loss — $4,21. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:MNOVLong
by KozakHlib